Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma ; volume:41 ; number:1 ; day:22 ; month:10 ; year:2022 ; pages:1-21 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (22.10.2022), 1-21, 12.2022
- Creator
-
Li, Meng
Han, Yujie
Wang, Chaochen
Kang, Wenfeng
Jiang, Wenyan
Zhang, Lei
Tang, Yujie
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02506-y
- URN
-
urn:nbn:de:101:1-2023010621002866019598
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Meng
- Han, Yujie
- Wang, Chaochen
- Kang, Wenfeng
- Jiang, Wenyan
- Zhang, Lei
- Tang, Yujie
- SpringerLink (Online service)
Other Objects (12)
Dissecting the genomic complexity underlying medulloblastoma
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Dissecting super-enhancer hierarchy based on chromatin interactions
Dissecting the OCT4-governed enhancer landscape in mouse embryonic stem cells
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Medulloblastoma cerebelli
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Expression of somatostatin receptor subtype 2 (sst2) is a prognostic marker and therapeutic target in high risk medulloblastoma
Raman spectroscopy for medulloblastoma
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Exclusion of Dependencies.
Handling Transitive Dependencies
Dissecting the genomic complexity underlying medulloblastoma
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Dissecting super-enhancer hierarchy based on chromatin interactions
Dissecting the OCT4-governed enhancer landscape in mouse embryonic stem cells
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Medulloblastoma cerebelli
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Expression of somatostatin receptor subtype 2 (sst2) is a prognostic marker and therapeutic target in high risk medulloblastoma
Raman spectroscopy for medulloblastoma
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Exclusion of Dependencies.
Handling Transitive Dependencies
Dissecting the genomic complexity underlying medulloblastoma
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Dissecting super-enhancer hierarchy based on chromatin interactions
Dissecting the OCT4-governed enhancer landscape in mouse embryonic stem cells
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Medulloblastoma cerebelli
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Expression of somatostatin receptor subtype 2 (sst2) is a prognostic marker and therapeutic target in high risk medulloblastoma
Raman spectroscopy for medulloblastoma
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Exclusion of Dependencies.